CircLATS2 Regulates miR-520a-3p/E2F7/p-VEGFR2 Signaling Pathway to Promote Hepatocellular Carcinoma Progression and Angiogenesis

Figure 4

Knockdown circLATS2 inhibited the malignant behavior of HCC cell in vitro experiments. (a) CCK-8 assay was used to detect the effect of circLATS2 on cell proliferation. (b) The effect of circLATS2 on cell clone formation ability was detected. Transwell assay was used to detect the effects of circLATS2 on cell migration (c) and invasion (d). HCC: hepatocellular carcinoma; CCK-8: Cell Counting Kit-8.

(a)

(b)

(c)

(d)